Befejeződött1. fázis
Phase 1b safety study of xevinapant, weekly cisplatin, and radiotherapy in participants with unresected LA SCCHN
Key facts
- Where
- Edegem, Gent, Kortrijk, Libramont-Chevigny és Sint-Niklaas, BelgiumSee the 5 sites
- Phase
- 1. fázis
Where in Belgium
- Antwerp University HospitalEdegem, BelgiumNo longer taking part
- Universitair Ziekenhuis GentGent, BelgiumNo longer taking part
- Algemeen Ziekenhuis GroeningeKortrijk, BelgiumNo longer taking part
- Hopital De LibramontLibramont-Chevigny, BelgiumNo longer taking part
- VitazSint-Niklaas, BelgiumNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Merck Healthcare KGaA
- Trial code
- EU 2023-505796-76-00
- Record updated
- 2024. június 6.